Renaissance Technologies
RBOT

Renaissance Technologies’s Vicarious Surgical RBOT Stock Holding History

Renaissance Technologies’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,134
Closed -$83.5K – 3832
2025
Q2 		$83.5K Sell
11,134
-1,500
-12% -$10.9K ﹤0.01% 3328
2025
Q1 		$82.9K Buy
12,634
+1,100
+10% +$13K ﹤0.01% 3224
2024
Q4 		$152K Buy
11,534
+1,200
+12% +$12.3K ﹤0.01% 3226
2024
Q3 		$58.7K Buy
+10,334
New +$68.6K ﹤0.01% 3328
2024
Q2 		– Sell
-6,327
Closed -$57K – 3880
2024
Q1 		$57K Sell
6,327
-16,531
-72% -$197K ﹤0.01% 3462
2023
Q4 		$251K Sell
22,858
-169
-0.7% -$1.88K ﹤0.01% 3055
2023
Q3 		$408K Buy
23,027
+14,450
+168% +$526K ﹤0.01% 2805
2023
Q2 		$471K Sell
8,577
-236
-3% -$15K ﹤0.01% 2903
2023
Q1 		$600K Buy
8,813
+7,380
+515% +$574K ﹤0.01% 2784
2022
Q4 		$87K Buy
+1,433
New +$133K ﹤0.01% 3662

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies's RBOT Position: Q3 2025 in Review

Renaissance Technologies sold out of Vicarious Surgical (RBOT) in Q3 2025, closing a stake of 11,134 shares — an estimated $83.5K sold.

Renaissance Technologies first reported a position in RBOT in Q4 2022 and held it in 10 quarters. The position peaked at $600K in Q1 2023. 32 funds tracked by Wall St. Rank hold RBOT as of Q3 2025.

  • Renaissance Technologies reported no remaining Vicarious Surgical position as of Q3 2025 after selling out during the quarter.
  • Renaissance Technologies sold 11,134 Vicarious Surgical shares in Q3 2025, an estimated $83.5K.
  • Renaissance Technologies first reported a position in Vicarious Surgical in Q4 2022 and held it in 10 quarters.
  • Renaissance Technologies's Vicarious Surgical position peaked at $600K in Q1 2023.
  • 32 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.